Cardiac efficiency improvement after slow continuous ultrafiltration is assessed by beat-to-beat minimally invasive monitoring in congestive heart failure patients: A preliminary report

Blood Purification

Volumn 29, Issue 1, 2010, Pages 44-51

  Giglioli, Cristina ^a   Landi, Daniele ^a   Gensini, Gian Franco ^a   Valente, Serafina ^a   Cecchi, Emanuele ^a   Scolletta, Sabino ^a   Chiostri, Marco ^a   Romano, Salvatore M ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Congestive heart failure; Heart failure; Hemodynamic monitoring; Minimally invasive surgery; Ultrafiltration

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; DIURETIC AGENT;

AGED; ANALYTIC METHOD; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; DYSPNEA; EDEMA; FEMALE; HEART BEAT; HEART CYCLE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE DP-DT; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART RATE VARIABILITY; HEART STROKE VOLUME; HUMAN; MALE; MEAN ARTERIAL PRESSURE; PATIENT MONITORING; PRIORITY JOURNAL; RADIAL ARTERY; SYSTEMIC VASCULAR RESISTANCE; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE; ULTRAFILTRATION; BLOOD PRESSURE; HEART FAILURE; HEART RATE; HEMODYNAMICS; HEMOFILTRATION; METHODOLOGY; MONITORING; PATHOPHYSIOLOGY; PHYSIOLOGY; PILOT STUDY; TREATMENT OUTCOME; VASCULAR RESISTANCE;

AGED, 80 AND OVER; BLOOD PRESSURE; CARDIAC OUTPUT; DIURETICS; EDEMA; HEART FAILURE; HEART RATE; HEMODYNAMICS; HEMOFILTRATION; HUMANS; MONITORING, PHYSIOLOGIC; NATRIURETIC PEPTIDE, BRAIN; PILOT PROJECTS; TREATMENT OUTCOME; VASCULAR RESISTANCE;

EID: 70449503614     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000258552     Document Type: Article

References (33)

1. Stevenson LW: Design of therapy for advanced heart failure. Eur J Heart Fail 2005;7:323-331.
2. Nieminen MS, Böhm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, Hasin Y, Lopez-Sendon J, Mebazaa A, Metra M, Rhodes A, Swedberg K, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie MR, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, Morais J, Oto A, Smiseth OA, Garcia MA, Dickstein K, Albuquerque A, Conthe P, Crespo-Leiro M, Ferrari R, Follath F, Gavazzi A, Ja ns s e n s U, Komajda M, Mora is J, Moreno R, Singer M, Singh S, Tendera M, Thygesen K, ESC Committe for Practice Guideline (CPG). Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26:384-416.
3. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, Tavazzi L, Smiseth OA, Gavazzi A, Haverich A, Hoes A, Jaarsma T, Korewicki J, Lévy S, Linde C, Lopez-Sendon JL, Nieminen MS, Piérard L, Remme WJ, Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology: Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26:1115-1140.
4. Bart BA, Boyle A, Bank AJ, et al: Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients with Decompensated Congestive Heart Failure (RAPID-CHF) trial. J Am Coll Cardiol 2005;46:2043-2046.
5. Costanzo MR, Saltzberg M, O'Sullivan J, et al: Early ultrafiltration in patients with decompensated heart failure and diuretic resistance. J Am Coll Cardiol 2005;46:2047-2051.
6. Costanzo MR, Guglin ME, Saltzberg MT, Jessup ML, Bart BA, Teerlink JR, Jaski BE, Fang JC, Feller ED, Haas GJ, Anderson AS, Schollmeyer MP, Sobotka PA, UNLOAD Trial Investigators: Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2007;49:675-683.
7. Binanay C, Califf RM, Hasselblad V, O'Connor CM, Shah MR, Sopko G, Stevenson LW, Francis GS, Leier CV, Miller LW, ESCAPE Investigators and ESCAPE Study Coordinators: Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA 2005;294:1625-1633.
8. Romano SM, Pistolesi M: Assessment of cardiac output from systemic arterial pressure in humans. Crit Care Med 2002; 30:1834-1841.
9. Giomarelli P, Scolletta S, Biagioli B: Cardiac output monitoring by pressure recording analytical method in cardiac surgery. Eur J Cardiothorac Surg 2004;26:515-520.
10. Romano SM, Scolletta S, Olivotto I, et al: Systemic arterial waveform analysis and assessment of blood flow during extracorporeal circulation. Perfusion 2006; 21:109-116.
11. Pinsky MR: Rationale for cardiovascular monitoring. Curr Opin Crit Care 2003;9:222-224.
12. Sorbara C, Romagnoli S, Rossi A, et al: Circulatory failure: bedside functional hemodynamic monitoring; in Atlee JL, Gullo A, Sinagra G, Vincent JL (eds): Perioperative Critical Care Cardiology, ed 2. Milan, Springer, 2007, pp 89-110.
13. Romano SM, Olivotto I, Chiostri M, et al: Minimally invasive and noninvasive haemodynamic monitoring of the cardiovascular system: available options and future perspectives. Curr Cardiol Rev 2006; 4:37-39.
14. Tulli G, Romano SM, Feminò R: Haemodynamic monitoring of septic patients with Pressure Recording Analytical Method: preliminary observations; in Gullo A (ed): Anaesthesia, Pain, Intensive Care and Emergency A.P.I.C.E. Milan, Springer, 2005, pp 323-329.
15. Mendoza DD, Cooper HA, Panza JA: Cardiac power output predicts mortality across a broad spectrum of patients with acute cardiac disease. Am Heart J 2007; 153:366-370.
16. Cotter G, Williams SG, Vered Z, et al: Role of cardiac power in heart failure. Curr Opin Cardiol 2003; 18:215-222.
17. Libetta C, Sepe V, Zucchi M, et al: Standard haemodiafiltration improves diuretic responsiveness in advanced congestive heart failure. Ca rdiolog y 2006; 105:122-123.
18. Butler J, Forman DE, Abraham WT, et al: Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J 2004;147:331-338.
19. Hillege HL, Girbes ARJ, De Kam PJ, et al: Renal function, neurohormonal activation and survival in patients with chronic heart failure. Circulation 2000; 102:203-210.
20. Boyle A, Sobotka PA: Redefining the therapeutic objective in decompensated heart failure: hemoconcentration as a surrogate for plasma refill rate. J Card Fail 2006; 12:247-249.
21. Marenzi G, Grazi S, Giraldi F, et al: Interrelation of humoral factors, haemodynamics, and fluid and salt metabolism in congestive heart failure: effects of extracorporeal ultrafiltration. Am J Med 1993; 94:49-56.
22. Marenzi G, Lauri G, Grazi M, et al: Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J Am Coll Cardiol 2001; 38:963-968.
23. Agostoni P, Marenzi G, Lauri G, et al: Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result. Am J Med 1994;96:191-199.
24. Romano SM, Lazzeri C, Chiostri M, et al: Beat-to-beat analysis of pressure wave morphology for pre-symptomatic detection of orthostatic intolerance head-up tilt. J Am Coll Cardiol 2004; 44:1891-1897.
25. Marenzi G, Agostoni P, Guazzi M, et al: The noradrenaline plasma concentration and its gradient across the lung. Eur J Clin Invest 2000;30:660-667.
26. Rowell LB: Human Cardiovascular Control. New York, Oxford University Press, 1993, p 268.
27. Brett SE, Ritter JM, Chowienczyk PJ: Diastolic blood pressure changes during exercise positively correlate with serum cholesterol and insulin resistance. Circulation 2000; 101:611-615.
28. Carabello BA: Evolution of the study of left ventricular function: everything old is new again. Circulation 2002;105:2701-2703.
29. Jaski BE, Ha J, Denys BG, et al: Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients. J Card Fail 2003; 9:227-231.
30. Hoffmann JN, Faist E: Removal of mediators by continuous haemofiltration in septic patients. World J Surg 2001;25:651-659.
31. Tallman RD, Dumond M, Brown D: Inflammatory mediator removal by zero-balance ultrafiltration during cardiopulmonary bypass. Perfusion 2002; 17:111-115.
32. Agostoni PG, Marenzi GC: Sustained benefit from ultrafiltration in moderate congestive heart failure. Cardiology 2001;96:183-189.
33. Agostoni PG, Guazzi M, Bussotti M, et al: Lack of improvement of lung diffusing capacity following fluid withdrawal by ultrafiltration in chronic heart failure. J Am Coll Cardiol 2000;36:1600-1604.